Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 Million - Analysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More

globenewswire.com
DHR Danaher is mentioned as a key player in the U.S. Exosomes market, which is projected to grow significantly. The article does not provide specific sentiment towards Danaher's performance or its role in this market. TMO Thermo Fisher Scientific is listed as a key player in the U.S. Exosomes market, which is expected to experience substantial growth. The article does not offer specific sentiment regarding the company's performance or its involvement in this sector.

U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 Million - Analysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "U.S. Exosomes Market Size, Share & Trends Analysis Report by Product & Service, Application, Workflow, End Use, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The U.S. exosomes market size, valued at USD 115.6 million in 2025, is projected to surge to USD 716.8 million by 2033, marking a robust CAGR of 25.75% from 2026 to 2033. The market's expansion is largely driven by advancements in exosome applications, particularly emphasizing their evolving role in cancer detection and treatment. Technological innovations in exosome isolation and analytical methodologies are significantly contributing to this growth trajectory.

The surging incidence of cancer has become a pivotal factor in the market's growth dynamics. With over 2 million new cancer cases in the U.S. alone in 2025, the demand for innovative diagnostic tools is critical. Exosomes are being recognized for their potential to serve as biomarkers in early cancer detection, disease monitoring, and therapeutic response assessment. This trend underscores the growing necessity for exosome-based technologies in the healthcare sector.

U.S. Exosomes Market Report Segmentation

The comprehensive market report provides detailed revenue forecasts and analyses of the prevailing trends in each sub-segment from 2021 to 2033. The segmentation includes:

Product & Service Outlook (Revenue, USD Million, 2021-2033)

Workflow Outlook (Revenue, USD Million, 2021-2033)

Application Outlook (Revenue, USD Million, 2021-2033)

End Use Outlook (Revenue, USD Million, 2021-2033)

Why You Should Buy This Report

This report addresses:

Key Attributes

The leading players profiled in this U.S. Exosomes market report include:

For more information about this report visit https://www.researchandmarkets.com/r/zi7jq0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment